Status:

COMPLETED

Monitoring of Fluid Status in Heart Failure Patients by Intrathoracic Impedance Measurement in Japan (J-HomeCARE II)

Lead Sponsor:

Biotronik Japan, Inc.

Conditions:

Heart Failure

Arrhythmias, Cardiac

Eligibility:

All Genders

18+ years

Phase:

PHASE4

Brief Summary

The new BIOTRONIK implantable cardioverter defibrillator (ICD) family Lumax 540 is capable of measuring the intrathoracic impedance on a daily basis and transmission of impedance trend data via the Ho...

Detailed Description

The new BIOTRONIK ICD family Lumax 540 is capable of measuring the intrathoracic impedance on a daily basis and transmission of impedance trend data via the Home Monitoring technology. In future, this...

Eligibility Criteria

Inclusion

  • Patient eligible for 1-, 2- or 3-chamber ICD implantation according to current guidelines or patient already implanted with a Lumax 540 device or successor
  • New York Heart Association (NYHA)-class II to IV
  • Left ventricular ejection fraction (LVEF) lower or equal to 35%
  • Patient accepts Home Monitoring concept and has sufficient Global System for Mobile Communications (GSM) /General Packet Radio Service (GPRS) net coverage
  • Increased risk for HF-related hospitalization according to pre-defined criteria
  • Patient information
  • Informed consent

Exclusion

  • Age \< 18 years
  • Contraindication for ICD implantation
  • Post heart transplant (HTX) or actively listed for HTX
  • Cardiac surgery within the previous 3 months or planned at time of inclusion
  • Acute coronary syndrome within the previous 3 months
  • Chronic renal dialysis
  • Pregnant or breast-feeding women
  • Limited contractual capability
  • Participation in another study
  • Anticipated non-compliance with the follow-up scheme
  • Life expectancy not longer than 1.5 years due to a non-cardiac disease

Key Trial Info

Start Date :

June 1 2010

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

February 1 2014

Estimated Enrollment :

198 Patients enrolled

Trial Details

Trial ID

NCT01221649

Start Date

June 1 2010

End Date

February 1 2014

Last Update

October 12 2015

Active Locations (4)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (4 locations)

1

Kokura Kinen Hospital

Kitakyushu, Fukuoka, Japan, 802-8555

2

Hiroshima Shimin Hospital

Hiroshima, Hiroshima, Japan

3

Yamada Red Cross Hospital

Ise, Mie-ken, Japan, 516-0805

4

Tokyo Women's Medical University

Tokyo, Tokyo, Japan